Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SCINAI IMMUNOTHERAPEUTICS LTD.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
Listen to this Section


$0.45
-0.0020 ( -0.44% ) 60.1K

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

Market Data


Open $0.45
Previous Close $0.45
Volume 60.1K
Market Cap $1.79M
Day Range $0.44 - $0.46
52 Week Range $0.41 - $6.18
Shares Outstanding 3.96M
Change % -0.44%
Net Change ▼ -0.0020
Insider Ownership N/A
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
IPO Year2015
CountryIsrael

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 4 Nov 13, 2025
6-k Form 6-K 5 Nov 13, 2025
6-k Form 6-K 2 Oct 06, 2025
6-k Form 6-K 1 Sep 22, 2025
6-k Form 6-K 2 Sep 11, 2025
6-k Form 6-K 54 Sep 02, 2025
6-k Form 6-K 3 Jun 12, 2025
6-k Form 6-K 2 Jun 05, 2025
6-k Form 6-K 3 Jun 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy